U.S. flag An official website of the United States government
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. CPG Sec. 654.200 Teat Dips and Udder Washes for Dairy Cows and Goats
  1. Search for FDA Guidance Documents

COMPLIANCE POLICY GUIDE (CPG)

CPG Sec. 654.200 Teat Dips and Udder Washes for Dairy Cows and Goats March 1995

Final
Issued by:
Guidance Issuing Office
Center for Veterinary Medicine
Office of Regulatory Affairs

BACKGROUND:

Teat Dips

Teat dips are drugs that are applied to the teats of lactating animals immediately following milking and removal of the milking machine to control the spread of mastitis. Since the control of mastitis is inherent in the purpose for using teat dips, the control of mastitis constitutes their intended use whether or not specifically labeled for this purpose. In the FEDERAL REGISTER of August 9, 1977 (42 FR 40217), the agency published a proposed regulation which would designate teat dips as new animal drugs and require them to be subject to approved NADAs. The proposed regulation has not been finalized. The comments submitted in response to the proposal and other factors have resulted in a reevaluation of the intended regulation. This Guide establishes agency policy pending final disposition of the proposed regulation.

Udder Washes

There are many products being marketed which are intended and labeled for cleansing the udders of lactating cows and goats prior to milking. Use of these products is consistent with the Grade "A" Pasteurized Milk Ordinance (1965 Recommendation of the United States Public Health Service) which includes the following statements:

The udders and teats of all milking cows shall be cleaned and treated with a sanitizing solution just prior to the time of milking, and shall be relatively dry before milking. Udder washes may be classified as animal drugs if formulated to contain one or more antimicrobial chemicals as active ingredients, and labeling includes claims for controlling mastitis or the spread of mastitis, or labeling includes other claims for controlling microorganisms in or on the animal.

POLICY:

Teat dips and udder washes classified as drugs, may currently be marketed without NADA approval. At some future time, these drug products may be required to comply with the NADA approval requirements of Section 512 of the Act.

Udder wash products promoted as cleansing agents and not classified as drugs could be required to be the subject of food additive regulations unless they are considered GRAS. This decision will be made on individual products based on directions for use and potential to contaminate milk and dairy products.

We do not expect to take regulatory action against teat dip and udder wash drug products on a 501(a)(5) charge unless we have specific information that a particular product may be harmful, or ineffective. The *Center for* Veterinary Medicine will continue to review the labeling of all teat dip and udder wash products and provide comment on their regulatory status and appropriateness of the labeling.

Manufacturers of teat dips and udder washes falling within the drug definition are subject to the registration and drug listing requirements of Section 510 of the Act. Part 211 of the GMP regulations is applicable to the manufacture of teat dips and drug udder washes.

*Material between asterisks is new or revised*

Issued: 7/1/82
Revised: 3/95


Submit Comments

Submit comments on this guidance document electronically via docket ID: FDA-2013-S-0610 - Specific Electronic Submissions Intended For FDA's Dockets Management Staff (i.e., Citizen Petitions, Draft Proposed Guidance Documents, Variances, and other administrative record submissions)

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All comments should be identified with the title of the guidance.

Questions?

Contact Point
CVM
Center for Veterinary Medicine
Food and Drug Administration
7500 Standish Pl, HFV-1
Rockville, MD 20855
AskCVM@fda.hhs.gov
(240) 402-7002